Design, Synthesis and Evaluation of -pyrazinylbenzamides as Potential Antimycobacterial Agents

about

Design, Synthesis and Evaluation of -pyrazinylbenzamides as Potential Antimycobacterial Agents

Item

http://www.wikidata.org/entity/Q58691665

description

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 18 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Design, Synthesis and Evaluati ...... ntial Antimycobacterial Agents

@en

Design, Synthesis and Evaluati ...... ntial Antimycobacterial Agents

@nl

type

Item

label

Design, Synthesis and Evaluati ...... ntial Antimycobacterial Agents

@en

Design, Synthesis and Evaluati ...... ntial Antimycobacterial Agents

@nl

prefLabel

Design, Synthesis and Evaluati ...... ntial Antimycobacterial Agents

@en

Design, Synthesis and Evaluati ...... ntial Antimycobacterial Agents

@nl

P1476

Design, Synthesis and Evaluati ...... ntial Antimycobacterial Agents

@en

P2093

Alžběta Mindlová

http://www.w3.org/2001/XMLSchema#string

Ondřej Valášek

http://www.w3.org/2001/XMLSchema#string

Pavla Paterová

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of pyrazinamide on fatty acid synthesis by whole mycobacterial cells and purified fatty acid synthase I.

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

Structural basis for targeting the ribosomal protein S1 of Mycobacterium tuberculosis by pyrazinamide

Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis

Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium

Biochemical characterization of quinolinic acid phosphoribosyltransferase from Mycobacterium tuberculosis H37Rv and inhibition of its activity by pyrazinamide

The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling

High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv.

Substituted aryl malonamates as new serine beta-lactamase substrates: structure-activity studies

Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis

P304

2390

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/MOLECULES23092390

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30231544

http://www.w3.org/2001/XMLSchema#string

P932

6225228

http://www.w3.org/2001/XMLSchema#string